Business Context and Reporting Period
Glucotrack, Inc. (GCTK), a Delaware corporation, filed this Form 8-K on August 28, 2026, to report the effective implementation of a one-for-fifteen (1-for-15) reverse stock split. The split was approved by stockholders on August 18, 2026, and became effective at 4:30 p.m. Eastern Time on August 28, 2026. The company's common stock began trading on a split-adjusted basis on August 31, 2026, under the same ticker symbol "GCTK" with a new CUSIP number.
Key Financial Metrics
This filing focuses on capital structure changes rather than operational performance. However, it provides restated historical financial data to reflect the reverse stock split. The company reported significant net losses across all periods presented, with no revenue or profit figures disclosed in this document.
- Net Loss (Year Ended Dec 31, 2025): $19,339,000
- Net Loss (Year Ended Dec 31, 2024): $22,573,000
- Net Loss (Six Months Ended June 30, 2026): $8,137,000
- Shares Outstanding (Post-Split): Approximately 798,144 shares (reduced from 11,972,157 pre-split).
- Authorized Shares: Remains 250,000,000.
The filing does not provide specific data on cash flow, debt levels, liquidity, or operating margins.
Material Changes Versus Prior Period
The primary material change is the reduction in the number of outstanding shares and the corresponding increase in the per-share accounting values due to the 1-for-15 reverse stock split.
- Share Count Reduction: Outstanding shares decreased from 11,972,157 to approximately 798,144 immediately prior to the effective time.
- Per Share Metrics: Historical net loss per share figures have been restated upward by a factor of 15. For example, the basic net loss per share for the year ended December 31, 2025, was restated from $31.22 (pre-split) to $468.30 (post-split).
- Derivative Adjustments: Stock options and warrants were adjusted proportionally, with corresponding increases to their exercise prices.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure regarding the reverse stock split mechanics. The document notes that fractional shares were not issued; instead, stockholders holding shares not evenly divisible by 15 received a round-up to the next whole share.
Investor Verification Checklist
- Verify the new CUSIP number (45824Q887) for trading purposes.
- Confirm the adjusted share count and exercise prices for any held stock options or warrants.
- Review the company's most recent Form 10-Q or 10-K for detailed operational metrics, as this 8-K only restates historical loss figures.
- Monitor the stock price performance post-split on August 31, 2026, to assess market reaction to the capital structure change.